These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 25111532

  • 21. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 22. Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
    Öhrfelt A, Axelsson M, Malmeström C, Novakova L, Heslegrave A, Blennow K, Lycke J, Zetterberg H.
    Mult Scler; 2016 Oct; 22(12):1587-1595. PubMed ID: 26754805
    [Abstract] [Full Text] [Related]

  • 23. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ.
    Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [Abstract] [Full Text] [Related]

  • 30. A new focal model resembling features of cortical pathology of the progressive forms of multiple sclerosis: Influence of innate immunity.
    Silva BA, Leal MC, Farías MI, Avalos JC, Besada CH, Pitossi FJ, Ferrari CC.
    Brain Behav Immun; 2018 Mar; 69():515-531. PubMed ID: 29378262
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The role of MRI of the brain and spinal cord, and CSF examination for the diagnosis of primary progressive multiple sclerosis.
    Nilsson P, Sandberg-Wollheim M, Norrving B, Larsson EM.
    Eur J Neurol; 2007 Nov; 14(11):1292-5. PubMed ID: 17764461
    [Abstract] [Full Text] [Related]

  • 33. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
    Augutis K, Axelsson M, Portelius E, Brinkmalm G, Andreasson U, Gustavsson MK, Malmeström C, Lycke J, Blennow K, Zetterberg H, Mattsson N.
    Mult Scler; 2013 Apr; 19(5):543-52. PubMed ID: 23069872
    [Abstract] [Full Text] [Related]

  • 34. Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis.
    DiSano KD, Linzey MR, Royce DB, Pachner AR, Gilli F.
    J Neuroinflammation; 2019 May 22; 16(1):109. PubMed ID: 31118079
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
    Osorio Y, La Point SF, Nusinowitz S, Hofman FM, Ghiasi H.
    Exp Neurol; 2005 May 22; 193(1):1-18. PubMed ID: 15817260
    [Abstract] [Full Text] [Related]

  • 37. Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic.
    Wong JK, Lin J, Kung NJ, Tse AL, Shimshak SJE, Roselle AK, Cali FM, Huang J, Beaty JM, Shue TM, Sadiq SA.
    Brain; 2023 May 02; 146(5):1979-1992. PubMed ID: 36732292
    [Abstract] [Full Text] [Related]

  • 38. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh, Emmanouilidou E, Gasparinatos G, Velona T, Voumvourakis KI, Stefanis L.
    J Neurochem; 2015 Aug 02; 134(4):748-55. PubMed ID: 25962981
    [Abstract] [Full Text] [Related]

  • 39. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP, Piddlesden S, Morgan BP, Reynolds R.
    Exp Neurol; 1994 Oct 02; 129(2):299-310. PubMed ID: 7525334
    [Abstract] [Full Text] [Related]

  • 40. Early glial responses in murine models of multiple sclerosis.
    Ayers MM, Hazelwood LJ, Catmull DV, Wang D, McKormack Q, Bernard CC, Orian JM.
    Neurochem Int; 2004 Oct 02; 45(2-3):409-19. PubMed ID: 15145555
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.